Infectious disease
Cue Health went public on September 24 on the Nasdaq securities exchange under the ticker symbol HLTH.
Population demographics appear to play a crucial role in the development of immunity via vaccination.
Teamed up with pharma giant GlaxoSmithKline, CureVac is now focusing on a more promising target – second-generation mRNA vaccines.
Although there are many effective and safe COVID-19 vaccines around the world, the preferred vaccine is the Pfizer-BioNTech vaccine. For that and more stories, read on.
Evidence is emerging that not only can COVID-19 vaccines help to prevent the condition, but they could serve as a form of “rescue” for those already stricken with it.
According to Fauci, kids can safely go trick-or-treating outdoors this Halloween. He did add that children who are eligible for COVID-19 vaccinations should do so for an “extra degree of protection.”
If authorized, it could be available in the U.S. before the end of the year. It is also working to submit applications to other regulators worldwide.
As US vaccination rates have been hovering in the 50% of the population range for two months, President Biden hit the old dusty trail to push his vaccine mandate even more.
Here’s a look at mRNA vaccines and their effectiveness and more COVID-19 news.
PRESS RELEASES